{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:01:00Z","timestamp":1781715660983,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.conctc.2026.101641","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:37:02Z","timestamp":1776285422000},"page":"101641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Standardization of clinical trials subject ID schematics: A portfolio-wide model to enhance data integrity and regulatory compliance"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4204-3127","authenticated-orcid":false,"given":"Ananya","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Demas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Bazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2026.101641_bib1","series-title":"Technical Conformance Guide: Study Data for Submission to CDER and CBER. Silver Spring (MD)","year":"2023"},{"key":"10.1016\/j.conctc.2026.101641_bib2","series-title":"Study Data Tabulation Model (SDTM) Implementation Guide","year":"2024"},{"key":"10.1016\/j.conctc.2026.101641_bib3","series-title":"E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1)","year":"2016"},{"key":"10.1016\/j.conctc.2026.101641_bib4","series-title":"PhUSE\/PharmaSUG Conference Proceedings","article-title":"Portfolio-wide standardization of subject ID schematics in clinical trials","author":"Jain","year":"2021"},{"key":"10.1016\/j.conctc.2026.101641_bib5","series-title":"Guideline on Computerised Systems and Electronic Data in Clinical Trials","year":"2023"},{"key":"10.1016\/j.conctc.2026.101641_bib6","series-title":"M11: Clinical Electronic Structured Protocol Template","year":"2024"},{"key":"10.1016\/j.conctc.2026.101641_bib7","series-title":"Internal Clinical Subject ID Schematics Data Integrity & Operational Framework","year":"2020"},{"key":"10.1016\/j.conctc.2026.101641_bib8","series-title":"Data Standards Catalog v8.1. Silver Spring (MD)","year":"2024"},{"key":"10.1016\/j.conctc.2026.101641_bib9","series-title":"Best Practices for Subject Identification and De-Identification in Clinical Research","year":"2021"},{"key":"10.1016\/j.conctc.2026.101641_bib10","series-title":"General Data Protection Regulation (EU 2016\/679)","year":"2016"},{"key":"10.1016\/j.conctc.2026.101641_bib11","series-title":"Portfolio-Wide Subject ID Adoption Report","year":"2025"},{"key":"10.1016\/j.conctc.2026.101641_bib12","series-title":"Subject ID Schematics master-sheet Registry Compliance Audit","year":"2025"},{"key":"10.1016\/j.conctc.2026.101641_bib13","series-title":"System Compatibility Assessment of Standardized Subject Identifiers","year":"2024"},{"key":"10.1016\/j.conctc.2026.101641_bib14","series-title":"Study Data Validator Tool Performance Report","year":"2024"},{"key":"10.1016\/j.conctc.2026.101641_bib15","series-title":"Data Standards and Traceability in Regulatory Submissions Report","year":"2024"},{"key":"10.1016\/j.conctc.2026.101641_bib16","series-title":"Data Quality by Design in Subject Identifier Management","year":"2020"},{"key":"10.1016\/j.conctc.2026.101641_bib17","series-title":"M11 Clinical Electronic Structured Protocol Template Draft Report","year":"2024"},{"key":"10.1016\/j.conctc.2026.101641_bib18","series-title":"NextGen Study Data Review Tool Pilot Summary. Silver Spring (MD)","year":"2025"},{"key":"10.1016\/j.conctc.2026.101641_bib19","series-title":"Best Practices for Data Traceability and De-Identification in Multicenter Trials. Durham (NC): CTTI","year":"2022"},{"key":"10.1016\/j.conctc.2026.101641_bib20","article-title":"Proposal for extended subject identifier Metadata model","year":"2025","journal-title":"Austin (TX): CDISC"}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865426000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865426000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:03:03Z","timestamp":1781712183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865426000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":20,"alternative-id":["S2451865426000487"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2026.101641","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standardization of clinical trials subject ID schematics: A portfolio-wide model to enhance data integrity and regulatory compliance","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2026.101641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101641"}}